Bernie Sanders visits Canadian pharmacy, talks drug prices

Published 07/28/2019, 04:54 PM
© Reuters. U.S. citizen Jillian Rippolone, who lives with type 1 diabetes, talks to U.S. Sen. Bernie Sanders about the high cost of U.S. health care inside the Canadian pharmacy in Windsor, Ontario

By Derek Spalding

WINDSOR, Ontario (Reuters) - U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the border on Sunday to buy cheap insulin in Canada, highlighting his argument in favor of federally negotiated prescription drug prices.

Sitting in the back of a chartered bus organized by members of advocacy group Insulin4All, Sanders spoke to families who said they go to great lengths to ration their insulin because of high U.S. costs, often putting their health at risk.

"We should be doing what the Canadians do, and that means sitting down with the drug companies and negotiating a price," he said.

Democrats seeking to take the White House in 2020 see President Donald Trump as increasingly vulnerable to criticism on healthcare costs, since his administration has failed to push through several initiatives to lower drug prices.

Kathy Sego and her son Hunter, 22, picked up six months worth of insulin from the Olde Walkerville Pharmacy in Windsor, Ontario, across the river from Detroit, spending a little more than $1,000.

"That's still less than what I pay a month in the United States," Sego said, fighting back tears.

Stephanie Odette, 30, said she started to ration her supply when she was in college.

"I was hospitalized 74 times ... which has got to be some sort of a record," she said.

Drug manufacturers say they have to raise U.S. list prices to help offset steep rebates they must offer to get drugs covered by insurance plans.

The U.S. government should set drug costs based on the average prices in six other countries, including Canada, Sanders said. He also called again for the United States to allow healthcare providers and others to import drugs to reduce costs.

"I believe we should be able to import into the United States from Canada, and from other countries, FDA-approved medicine, which would substantially lower prices," he said.

While manufacturers ship their drugs across borders, they set different prices in different countries, and other companies are generally not allowed to import drugs meant for other markets.

Several U.S. states have passed laws to allow large-scale imports, but shipments would not be legal without federal approval. The Health and Human Services secretary said in early July the government was looking at the issue.

© Reuters. U.S. citizen Jillian Rippolone, who lives with type 1 diabetes, talks to U.S. Sen. Bernie Sanders about the high cost of U.S. health care inside the Canadian pharmacy in Windsor, Ontario

Reuters reported earlier this month that Canadian officials have warned the United States they would oppose any imports that raise drug prices or cause shortages in Canada.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.